RAB37 and hyperlipidemia: Our data indicate that the decrease in Rab37 expression is at least in part mediated by ICER, a transcriptional repressor that is believed to contribute to β-cell failure evoked by chronic hyperglycemia, hyperlipidemia and oxLDL [11], [16], [34].